Recordati stock holds steady as latest FTSE MIB data show modest gain

Published on 09/17/2026 at 12:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Recordati stock closed at EUR 52.75 on Euronext Milan on September 16, 2026, up 0.19 percent from the prior session. The pharmaceutical group continues to build on recent results and a growing specialty portfolio.

Recordati, IT0003828271, Illustration mit AI erstellt.

Recordati stock (ISIN IT0003828271) closed the last completed trading session on Euronext Milan at EUR 52.75 on September 16, 2026, marking a 0.19 percent gain over the prior close according to official FTSE MIB data from Borsa Italiana for Recordati Ord.

Stock performance around mid-September

At the close on September 16, 2026, Recordati Ord was quoted at EUR 52.75 on Euronext Milan, with the index overview of daily performances showing a price of EUR 52.75 and a daily change of plus 0.19 percent for the stock.

Based on the same data set for FTSE MIB components, the closing level of EUR 52.75 on September 16, 2026, places Recordati stock moderately above earlier levels seen in late summer, while remaining below typical 52-week highs for Italian large caps in the pharmaceutical segment.

Business profile and recent financial context

Recordati is an international pharmaceutical group listed on the Italian Stock Exchange under the ticker REC, focused on specialty and rare disease treatments and operating in Europe, the Americas and other markets.

According to information published by the company on its investor relations pages, Recordati reported recent interim financial figures for its latest half-year period within the last nine months, including revenue growth in the low double-digit percent range compared with the same period of the prior year and an increase in operating profit that outpaced sales growth, reflecting a positive margin development.

Investor perspective on valuation and sector backdrop

For investors, the current price level of EUR 52.75 as of September 16, 2026, means that Recordati stock trades at a valuation supported by its specialty pharmaceutical focus, with the modest 0.19 percent daily gain in the latest session fitting into a broader pattern of relatively stable trading for Italian healthcare names.

The interplay between defensive characteristics of pharmaceutical earnings and the cyclical moves of the FTSE MIB index is likely to remain a key factor for Recordati shareholders, especially as markets react to macroeconomic signals and sector-specific news in the coming months.

Recordati stock and recent closing price

Recordati stock last closed at EUR 52.75 on Euronext Milan on September 16, 2026, with the price move of plus 0.19 percent providing a small but positive contribution to investors focused on stable dividend-paying healthcare stocks.